Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil, a medicine initially for high blood pressure, can stimulate hair growth and is promising for treating hair loss, but it may cause side effects like itching and dizziness.

Overexpression of HDGF in melanocytes does not cause cancer.

DHEA affects various tissues by interacting with multiple receptors and can be converted into sex hormones.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Collagen makes skin stiff, and preservation methods greatly increase tissue stiffness.

Improving mitochondrial health may better treat atherosclerosis than antioxidants.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Some existing medicines show promise as safe treatments to protect against the side effects of radiation therapy.

Vitamin E affects liver metabolism, enhancing stress resistance, reducing blood clotting, and altering hormone processing.

Cantú syndrome is caused by mutations in the ABCC9 gene.

New therapies are being developed that target integrin pathways to treat various diseases.

RNA delivery is best for in-body use, while RNP delivery is good for outside-body use. Both methods are expected to greatly impact future treatments.

Progeroid mouse models show signs of early aging similar to humans, helping us understand aging better.

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

TLR4 is important in aging-related diseases and could be a new treatment target.

Special gels help heal diabetic foot sores and reduce the risk of amputation or death.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

Dermal factors are crucial in regulating melanin production in skin.

Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

DHEA affects multiple receptors and may help with metabolic issues, but its safety and effectiveness in humans are unclear.

Hair loss in middle-aged women is often linked to insulin resistance and a family history of hair loss, particularly from their fathers.

Gene therapy shows promise for healing chronic wounds but needs more research to overcome challenges.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

MicroRNA-21 could help diagnose and treat skin fibrosis.